CAEP is now proud to offer Live & On-Demand Education Webinars and Interactive Content. Check back often for updated content as well as archived recordings!

Featured Programming:

Register

What’s New in Acquired Hemophilia & Rare Bleeding Disorders: Pearls for the Emergency Physician – Mar 16, 2021
Click here to register

Immune-related Adverse Events of Immune Checkpoint Inhibitors: What Emergency Physicians Need to Know – Mar 25, 2021
Click here to register

What’s New in Acquired Hemophilia & Rare Bleeding Disorders: Pearls for the Emergency Physician

Tuesday, March 16th, 2021 @ 1:00pm EST

This is an area that is fraught with uncertainty and potential for errors. Unexplained bleeding (not related to anti-coagulant therapy) for both known and unknown bleeding disorders represent a diagnostic and management challenge for ED physicians.

At this end of this presentation, participants will be able to:

Confidently recognize and initiate appropriate investigations in a patient with unusual bleeding or unexplained coagulation abnormalities
Manage acute bleeding and pre-procedural treatment for patients with rare bleeding disorders and rare presentations of rare bleeding disorders
Be aware of new therapeutic agents for treatment of hemophilia and how patient care plans can improve care delivery for patients with rare bleeding disorders in the ED setting.

This Group Learning program has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 1.00 Mainpro+ credit.

This webinar is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada and approved by Canadian Association of Emergency Physicians. You may claim a maximum of 1 hour(credits are automatically calculated).

Moderated By:

Eddy Lang, CCFP-EM

Professor and Department Head for Emergency Medicine
Cumming School of Medicine, University of Calgary
Alberta Health Services, Calgary Zone

Speaker:

Adrienne Lee, MD FRCPC

Clinical Associate Professor
Department of Medicine, University of Calgary
Division of Hematology & Hematologic Malignancies

Registration is Free – Sign Up Today!

Immune-related Adverse Events of Immune Checkpoint Inhibitors: What Emergency Physicians Need to Know

Thursday, March 25, 2021 @ 1:00pm EST

Immune checkpoint inhibitors are becoming more common in the treatment of many malignancies, including, melanoma, lung, and colorectal cancer.

As the use of immune checkpoint inhibitors increases, EDs are seeing increasing numbers of patients presenting with immune-related adverse events (IRAE) from these agents which can mimic other conditions. Failure to recognize and treat these in a timely manner can lead to avoidable poor patient outcomes.

At this end of this presentation, participants will be able to:

Identify commonly used immune checkpoint inhibitors and understand their basic pathophysiology
Recognize and diagnose common and rare presentations of checkpoint inhibitor toxicity
Differentiate toxicity-related pneumonitis from COVID-19-related pneumonitis
Recognize when steroid treatment is appropriate
Implement and use diagnostic and treatment algorithms as well as patient care plans in the ED setting.

This Group Learning program has been reviewed by the College of Family Physicians of Canada and is awaiting final certification by the College’s Ontario Chapter.

This webinar is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada and approved by Canadian Association of Emergency Physicians. You may claim a maximum of 1 hour (credits are automatically calculated).

Moderated By:

Peter Iracleous, MD